Cargando…
Cardiac risk factors limiting survival to liver transplantation in patients with nonalcoholic fatty liver disease
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) describes the hepatic manifestations of metabolic syndrome, which is estimated to affect 25% of adults, and currently represents the second most common indication for liver transplant in the United States. Studies have shown that patients with NAF...
Autores principales: | Delicce, Michael, Mauch, Joseph, Joseph, Abel, Lyu, Ruishen, Kren, Heather, Bartow, Rose, Ferchill, Donna, Fares, Maan, Wakim-Fleming, Jamile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376786/ https://www.ncbi.nlm.nih.gov/pubmed/36158912 http://dx.doi.org/10.4254/wjh.v14.i7.1398 |
Ejemplares similares
-
Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
por: Jiang, Yi, et al.
Publicado: (2021) -
Favorable clinical outcome of nonalcoholic liver cirrhosis patients with coronary artery disease: A population-based study
por: Tsai, Ming-Chang, et al.
Publicado: (2018) -
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022) -
Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
por: Choi, Catherine J, et al.
Publicado: (2020) -
Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Tan, You-Wen, et al.
Publicado: (2023)